UniProtKB/Swiss-Prot Q99626: Variant p.Pro293Ser

Homeobox protein CDX-2
Gene: CDX2
Feedback?

Variant information Variant position:

293 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Proline (P) to Serine (S) at position 293 (P293S, p.Pro293Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and hydrophobic (P) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs1805107 [ dbSNP | Ensembl ]

Sequence information Variant position:

293 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

313 The length of the canonical sequence.
Location on the sequence:

GPLRSVPEPLSPVSSLQASV P GSVPGVLGPTGGVLNPTVTQ The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         GPLRSVPEPLSPVSSLQASVPGSVPGVLGPTGGVLNPTVTQ

Mouse                         GALRSVPEPLSPVTSLQGSVPGSVPGVLGPAGGVLNSTVTQ

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 313	Homeobox protein CDX-2
Region	242 – 313	Disordered
Motif	283 – 295	4S motif; modulates transactivation activity and protein stability
Modified residue	283 – 283	Phosphoserine

Literature citations
Cloning and chromosome assignment of the human CDX2 gene.
Drummond F.J.; Putt W.; Fox M.; Edwards Y.H.;
Ann. Hum. Genet. 61:393-400(1997)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANT SER-293; Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis.
Mallo G.V.; Rechreche H.; Frigerio J.-M.; Rocha D.; Zweibaum A.; Lacasa M.; Jordan B.R.; Dusetti N.J.; Dagorn J.-C.; Iovanna J.L.;
Int. J. Cancer 74:35-44(1997)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANT SER-293; The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis.
Sivagnanasundaram S.; Islam I.; Talbot I.; Drummond F.; Walters J.R.; Edwards Y.H.;
Br. J. Cancer 84:218-225(2001)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANT SER-293; Isolation, characterization, and linkage mapping of the human caudal-type homeobox gene, CDX2/3.
Tanizawa Y.; Ueda K.; Inoue H.; Ayame H.; Aoki M.; Kuwano A.; German M.S.; Liu L.; Donis-Keller H.; Permutt M.A.; Oka Y.;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANT SER-293; The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]; VARIANT SER-293;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.